Skip To Main Content
{ "isEditMode": false, "isPublic": true, "context": "", "site": "campus-sanofi-cz", "currentLocale": "cs_CZ", "translationsPath": "" }
[{ event: `metadata`,device: /(tablet|ipad|playbook|silk)|(android(?!.*mobi))/i.test(navigator.userAgent) ? 'tablet' : (/Mobile|iP(hone|od)|Android|BlackBerry|IEMobile|Kindle|Silk-Accelerated|(hpw|web)OS|Opera M(obi|ini)/.test(navigator.userAgent) ? 'mobile' : 'desktop'),platform: `magnolia`,language: `cs`,siteType: `advise`,brandWebsiteType: `multibrand`,region: `emea`,country: `czech republic`,target: `hcp`,brand: `Multi-Brand`,gbu: `GBU - Specialty care`,pageName: `Transplantační medicína` }]
Určeno pro odbornou veřejnost
Campus
Věda
Podpora Pacienta
Produkty
Farmakovigilance
Přihlásit se
Registrovat se
Campus
Věda
Podpora Pacienta
Produkty
Farmakovigilance
Přihlásit se
Registrovat se
Search Term
View Full Results
Transplantační medicína
Nejnovější trendy
Prozkoumejte nejčtenější články a videa na Campus Sanofi
Seřadit
Nejnovější
Nejstarší
Abecedně
Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control
Číst více
Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control
Číst více
Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control
Číst více
Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control
Číst více
Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control
Číst více
Understanding Time-in-Range: Assessment, Targets, and Benefits for Optimal Glycemic Control
Číst více
Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs
Číst více
Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs
Číst více
Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs
Číst více
Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs
Číst více
Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs
Číst více
Real-world evidence of treatment intensification in people with T2D inadequately controlled on GLP-1 RAs
Číst více
«
‹
717
718
719
720
721
722
723
724
725
726
›
»